Systematic review shows 'smart drug' modafinil does enhance cognition

August 19, 2015, European College of Neuropsychopharmacology

The drug modafinil was developed to treat narcolepsy (excessive sleeping), but it is widely used off-licence as a 'smart drug' to promote cognitive enhancement, where qualities such as alertness and concentration are desired to assist someone with, for example, exam preparation. Past studies on sleep-deprived individuals have shown a strong positive effect of modafinil on these functions, but there has been less attention and scientific consensus on the drug's overall effectiveness as a cognitive enhancer in people that are not sleep-deprived - presumably the majority of people taking it. Now, a new systematic review, published online in the peer-reviewed journal European Neuropsychopharmacology shows that modafinil does indeed confer significant cognitive benefits in this group, at least on a particular subset of tasks.

Dr Ruairidh Battleday and Dr Anna-Katharine Brem from the University of Oxford and Harvard Medical School evaluated all research papers on with modafinil from January 1990 to December 2014. They found 24 studies dealing with different benefits associated with taking modafinil, including planning and decision making, flexibility, learning and memory, and creativity.

Unsurprisingly, they found that the performance-enhancing capacity of modafinil varied according to the task. What emerged was that the longer and more complex the task tested, the more consistently modafinil conferred .

Modafinil made no difference to working memory, or flexibility of thought, but did improve decision-making and planning. Very encouragingly, the 70% of studies that looked at the effects of modafinil on mood and side effects showed very little overall effect, although a couple reported insomnia, headache, stomach ache or nausea (which were also reported in the placebo group).

According to Ruairidh McLennan Battleday (University of Oxford):"This is the first overview of modafinil's actions in non-sleep-deprived individuals since 2008, and so we were able to include a lot of recent data. Interestingly, we found that the type of test used to assess modafinil's cognitive benefits has changed over the last few decades. In the past, people were using very basic tests of cognition, developed for neurologically-impaired individuals. In contrast, more recent studies have, in general, used more complex tests: when these are used, it appears that modafinil more reliably enhances cognition: in particular 'higher' brain functions that rely on contribution from multiple simple cognitive processes."

According to Anna-Katharine Brem (University of Oxford and Harvard Medical School):

"So, we ended up having two main conclusions: first, that, in the face of vanishingly few side effects in these controlled environments, modafinil can be considered a cognitive enhancer; and, second that we need to figure out better ways of testing normal or even supra-normal cognition in a reliable manner. However, we would like to stress the point that with any method used to enhance cognition, ethical considerations always have to be taken into account: this is an important avenue for future work to explore."

Professor Guy Goodwin, President of the European College of Neuropsychopharmacology (ECNP) commented:

"This overview suggests that, on current evidence, modafinil enhances cognition independent of its known effects in sleep disordered populations. Thus, the authors say that "modafinil may well deserve the title of the first well-validated pharmaceutical nootropic agent". In other words, it's the first real example of a 'smart drug', which can genuinely help, for example, with exam preparation. Previous ethical discussion of such agents has tended to assume extravagant effects before it was clear that there were any. If correct, the present update means the ethical debate is real: how should we classify, condone or condemn a drug that improves human performance in the absence of pre-existing cognitive impairment?

As the authors point out, modafinil is not licenced for this use, and it will not be because it would be outside the current terms of reference of regulatory bodies. The non-medical use of mind altering drugs has hitherto broadly conflicted with the work ethic of many societies, has been very popular but leads to a range of demonstrable harms. Regulation has been and remains problematic. We cannot know either if demand for in the same societies will actually be significant, whether society will be more accepting and how regulation will then be framed.

Explore further: 'Smart' drugs won't make smart people smarter

More information: Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: a systematic review, R.M. Battleday and A.-K. Brem, European Neuropsychopharmacology, DOI: 10.1016/j.euroneuro.2015.07.028

Related Stories

'Smart' drugs won't make smart people smarter

November 12, 2014
It is claimed one in five students have taken the 'smart' drug Modafinil to boost their ability to study and improve their chances of exam success. But new research into the effects of Modafinil has shown that healthy students ...

Modafinil doesn't improve NSCLC-related fatigue

April 30, 2014
(HealthDay)—The central nervous system stimulant modafinil is not effective in treating non-small-cell lung cancer-related fatigue, according to a study published online April 28 in the Journal of Clinical Oncology.

If you are impulsive, take modafinil and count to 10

February 1, 2013
Poor impulse control contributes to one's inability to control the consumption of rewarding substances, like food, alcohol, and other drugs. This can lead to the development of addiction. FDA-approved medications for alcoholism, ...

Modafinil reduces depression's severity when taken with antidepressants

November 27, 2013
A new study has concluded that taking the drug modafinil, typically used to treat sleep disorders, in combination with antidepressants reduces the severity of depression more effectively than taking antidepressants alone. ...

Recommended for you

New study questions use of talking therapy as a treatment for schizophrenia

July 20, 2018
The findings of the first meta-analysis examining the effectiveness of Cognitive Behavioural Therapy for psychosis (CBTp) on improving the quality of life and functioning and reducing distress of people diagnosed with schizophrenia ...

Perfectionism in young children may indicate OCD risk

July 19, 2018
Studying young children, researchers at Washington University School of Medicine in St. Louis found that kids who possess tendencies toward perfectionism and excessive self-control are twice as likely as other children to ...

Younger children tend to make more informed decisions

July 19, 2018
A new study from the University of Waterloo has found that in some ways, the older you get the worse your decision making becomes.

Finding well-being through an aerial, as opposed to ground-level, view of time

July 19, 2018
Do today and yesterday and tomorrow loom large in your thinking, with the more distant past and future barely visible on the horizon? That's not unusual in today's time-pressed world—and it seems a recipe for angst.

Are you prone to feeling guilty? Then you're probably more trustworthy, study shows

July 19, 2018
It turns out your mother was right: guilt is a powerful motivator.

Using an electronic device counteracts benefits of taking a break in nature, researchers find

July 19, 2018
Being in nature helps restore your brain's ability to focus attention on a task. But if you are checking social media on your phone or answering emails on your laptop – even if you are doing so while surrounded by trees ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

RobertKarlStonjek
not rated yet Aug 21, 2015
Long term use, as with the long term use of caffeine, may result in a drop in baseline performance so that after some period of regular use the drug does not raise performance above the previous non-drug baseline.

For instance those not taking any caffeine for a few months will find that their usual cup of coffee makes their hair feel like it is standing on end and they will be unable to sleep for up to 12 hours after the coffee.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.